Increased glutamate transporter-associated anion currents cause glial apoptosis in episodic ataxia 6

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Increased glutamate transporter-associated anion currents cause glial apoptosis in episodic ataxia 6. / Kovermann, Peter; Untiet, Verena; Kolobkova, Yulia; Engels, Miriam; Baader, Stephan; Schilling, Karl; Fahlke, Christoph.

In: Brain Communications, Vol. 2, No. 1, 22, 2020.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kovermann, P, Untiet, V, Kolobkova, Y, Engels, M, Baader, S, Schilling, K & Fahlke, C 2020, 'Increased glutamate transporter-associated anion currents cause glial apoptosis in episodic ataxia 6', Brain Communications, vol. 2, no. 1, 22. https://doi.org/10.1093/braincomms/fcaa022

APA

Kovermann, P., Untiet, V., Kolobkova, Y., Engels, M., Baader, S., Schilling, K., & Fahlke, C. (2020). Increased glutamate transporter-associated anion currents cause glial apoptosis in episodic ataxia 6. Brain Communications, 2(1), [22]. https://doi.org/10.1093/braincomms/fcaa022

Vancouver

Kovermann P, Untiet V, Kolobkova Y, Engels M, Baader S, Schilling K et al. Increased glutamate transporter-associated anion currents cause glial apoptosis in episodic ataxia 6. Brain Communications. 2020;2(1). 22. https://doi.org/10.1093/braincomms/fcaa022

Author

Kovermann, Peter ; Untiet, Verena ; Kolobkova, Yulia ; Engels, Miriam ; Baader, Stephan ; Schilling, Karl ; Fahlke, Christoph. / Increased glutamate transporter-associated anion currents cause glial apoptosis in episodic ataxia 6. In: Brain Communications. 2020 ; Vol. 2, No. 1.

Bibtex

@article{df76719965b247daa80736319c231249,
title = "Increased glutamate transporter-associated anion currents cause glial apoptosis in episodic ataxia 6",
abstract = "Episodic ataxia type 6 is an inherited neurological condition characterized by combined ataxia and epilepsy. A severe form of this disease with episodes combining ataxia, epilepsy and hemiplegia was recently associated with a proline to arginine substitution at position 290 of the excitatory amino acid transporter 1 in a heterozygous patient. The excitatory amino acid transporter 1 is the predominant glial glutamate transporter in the cerebellum. However, this glutamate transporter also functions as an anion channel and earlier work in heterologous expression systems demonstrated that the mutation impairs the glutamate transport rate, while increasing channel activity. To understand how these changes cause ataxia, we developed a constitutive transgenic mouse model. Transgenic mice display epilepsy, ataxia and cerebellar atrophy and, thus, closely resemble the human disease. We observed increased glutamate-activated chloride efflux in Bergmann glia that triggers the apoptosis of these cells during infancy. The loss of Bergmann glia results in reduced glutamate uptake and impaired neural network formation in the cerebellar cortex. This study shows how gain-of-function of glutamate transporter-associated anion channels causes ataxia through modifying cerebellar development.",
keywords = "glutamate transporters, chloride homeostasis, Bergmann glia, glial apoptosis, episodic ataxia, ACTIVE CASPASE-3 EXPRESSION, CEREBELLAR PURKINJE-CELLS, MOUSE MODEL, SYNAPTIC INHIBITION, CLIMBING FIBERS, RAT CEREBELLUM, IN-VIVO, MUTATION, HETEROGENEITY, MODULATION",
author = "Peter Kovermann and Verena Untiet and Yulia Kolobkova and Miriam Engels and Stephan Baader and Karl Schilling and Christoph Fahlke",
year = "2020",
doi = "10.1093/braincomms/fcaa022",
language = "English",
volume = "2",
journal = "Brain Communications",
issn = "2632-1297",
publisher = "Claredon/Oxford Univ. Press",
number = "1",

}

RIS

TY - JOUR

T1 - Increased glutamate transporter-associated anion currents cause glial apoptosis in episodic ataxia 6

AU - Kovermann, Peter

AU - Untiet, Verena

AU - Kolobkova, Yulia

AU - Engels, Miriam

AU - Baader, Stephan

AU - Schilling, Karl

AU - Fahlke, Christoph

PY - 2020

Y1 - 2020

N2 - Episodic ataxia type 6 is an inherited neurological condition characterized by combined ataxia and epilepsy. A severe form of this disease with episodes combining ataxia, epilepsy and hemiplegia was recently associated with a proline to arginine substitution at position 290 of the excitatory amino acid transporter 1 in a heterozygous patient. The excitatory amino acid transporter 1 is the predominant glial glutamate transporter in the cerebellum. However, this glutamate transporter also functions as an anion channel and earlier work in heterologous expression systems demonstrated that the mutation impairs the glutamate transport rate, while increasing channel activity. To understand how these changes cause ataxia, we developed a constitutive transgenic mouse model. Transgenic mice display epilepsy, ataxia and cerebellar atrophy and, thus, closely resemble the human disease. We observed increased glutamate-activated chloride efflux in Bergmann glia that triggers the apoptosis of these cells during infancy. The loss of Bergmann glia results in reduced glutamate uptake and impaired neural network formation in the cerebellar cortex. This study shows how gain-of-function of glutamate transporter-associated anion channels causes ataxia through modifying cerebellar development.

AB - Episodic ataxia type 6 is an inherited neurological condition characterized by combined ataxia and epilepsy. A severe form of this disease with episodes combining ataxia, epilepsy and hemiplegia was recently associated with a proline to arginine substitution at position 290 of the excitatory amino acid transporter 1 in a heterozygous patient. The excitatory amino acid transporter 1 is the predominant glial glutamate transporter in the cerebellum. However, this glutamate transporter also functions as an anion channel and earlier work in heterologous expression systems demonstrated that the mutation impairs the glutamate transport rate, while increasing channel activity. To understand how these changes cause ataxia, we developed a constitutive transgenic mouse model. Transgenic mice display epilepsy, ataxia and cerebellar atrophy and, thus, closely resemble the human disease. We observed increased glutamate-activated chloride efflux in Bergmann glia that triggers the apoptosis of these cells during infancy. The loss of Bergmann glia results in reduced glutamate uptake and impaired neural network formation in the cerebellar cortex. This study shows how gain-of-function of glutamate transporter-associated anion channels causes ataxia through modifying cerebellar development.

KW - glutamate transporters

KW - chloride homeostasis

KW - Bergmann glia

KW - glial apoptosis

KW - episodic ataxia

KW - ACTIVE CASPASE-3 EXPRESSION

KW - CEREBELLAR PURKINJE-CELLS

KW - MOUSE MODEL

KW - SYNAPTIC INHIBITION

KW - CLIMBING FIBERS

KW - RAT CEREBELLUM

KW - IN-VIVO

KW - MUTATION

KW - HETEROGENEITY

KW - MODULATION

U2 - 10.1093/braincomms/fcaa022

DO - 10.1093/braincomms/fcaa022

M3 - Journal article

C2 - 32954283

VL - 2

JO - Brain Communications

JF - Brain Communications

SN - 2632-1297

IS - 1

M1 - 22

ER -

ID: 250112555